Detailed Mechanism Funding and Narrative

Years of mechanism: 2013 2014 2015 2016 2017

Details for Mechanism ID: 17119
Country/Region: Burundi
Year: 2017
Main Partner: FHI 360
Main Partner Program: NA
Organizational Type: NGO
Funding Agency: USDOD
Total Funding: $2,824 Additional Pipeline Funding: $339,363

NOTE: PEPFAR no longer creates activity narratives for each mechanism. In their place, PEPFAR has begun releasing mechanism specific targets that reveal the achievements and programs that are expected of the funding. If available for this mechanism, these targets are presented below.

Mechanism Allocation by Budget Code for Selected Year
Care: TB/HIV (HVTB) $0
Care: Pediatric Care and Support (PDCS) $0
Testing: HIV Testing and Counseling (HVCT) $0
Biomedical Prevention: Prevention of Mother to Child Transmission (MTCT) $0
Treatment: Adult Treatment (HTXS) $2,824
Treatment: Pediatric Treatment (PDTX) $0
Mechanism Target Information

Since COP2014, PEPFAR no longer produces narratives for every mechanism it funds. However, PEPFAR has now included performance targets or indicator information for each mechanism based on the Monitoring, Evaluation, and Reporting (MER) system. The MER guidance is available on PEPFAR's website https://www.pepfar.gov/reports/guidance/. Note that COP years 2014-2015 were under a previous version of the MER system and the indicators and definitions may have changed as of the new 2.0 guidance.

MER Indicator MER description Target Fiscal Year Target
HTS_TST Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2018 5,958
HTS_TST Service Delivery Point Agg Age (Facility) Index: <15, Female, Negative 2018 31
HTS_TST Service Delivery Point Agg Age (Facility) Index: <15, Male, Negative 2018 35
HTS_TST Service Delivery Point Agg Age (Facility) Index: 15+, Female, Negative 2018 12
HTS_TST Service Delivery Point Agg Age (Facility) Index: 15+, Male, Negative 2018 31
HTS_TST Service Delivery Point by Agg Age (Facility) ANC: 15+, Negative 2018 4,937
HTS_TST Service Delivery Point by Agg Age (Facility) Inpatient: <15, Female, Negative 2018 10
HTS_TST Service Delivery Point by Agg Age (Facility) Inpatient: <15, Male, Negative 2018 14
HTS_TST Service Delivery Point by Agg Age (Facility) Inpatient: 15+, Female, Negative 2018 52
HTS_TST Service Delivery Point by Agg Age (Facility) Inpatient: 15+, Male, Negative 2018 75
HTS_TST Service Delivery Point by Agg Age (Facility) Other PITC: 15+, Female, Negative 2018 47
HTS_TST Service Delivery Point by Agg Age (Facility) Other PITC: 15+, Male, Negative 2018 39
HTS_TST Service Delivery Point by Agg Age (Facility) TB: <15, Female, Negative 2018 4
HTS_TST Service Delivery Point by Agg Age (Facility) TB: 15+, Female, Negative 2018 18
HTS_TST Service Delivery Point by Agg Age (Facility) TB: 15+, Male, Negative 2018 25
HTS_TST Service Delivery Point by Agg Age (Facility) VCT: <15, Female, Negative 2018 8
HTS_TST Service Delivery Point by Agg Age (Facility) VCT: <15, Male, Negative 2018 3
HTS_TST Service Delivery Point by Agg Age (Facility) VCT: 15+, Female, Negative 2018 323
HTS_TST Service Delivery Point by Agg Age (Facility) VCT: 15+, Male, Negative 2018 185
HTS_TST Sum of Test Result disaggregates 2018 146
HTS_TST_POS By Test Result: Positive 2018 146
HTS_TST_POS Service Delivery Point Agg Age (Facility) Index: <15, Female, Positive 2018 2
HTS_TST_POS Service Delivery Point Agg Age (Facility) Index: <15, Male, Positive 2018 4
HTS_TST_POS Service Delivery Point Agg Age (Facility) Index: 15+, Female, Positive 2018 8
HTS_TST_POS Service Delivery Point Agg Age (Facility) Index: 15+, Male, Positive 2018 4
HTS_TST_POS Service Delivery Point by Agg Age (Facility) ANC: 15+, Positive 2018 48
HTS_TST_POS Service Delivery Point by Agg Age (Facility) Inpatient: <15, Male, Positive 2018 1
HTS_TST_POS Service Delivery Point by Agg Age (Facility) Inpatient: 15+, Female, Positive 2018 1
HTS_TST_POS Service Delivery Point by Agg Age (Facility) Inpatient: 15+, Male, Positive 2018 2
HTS_TST_POS Service Delivery Point by Agg Age (Facility) Other PITC: 15+, Female, Positive 2018 3
HTS_TST_POS Service Delivery Point by Agg Age (Facility) TB: 15+, Female, Positive 2018 1
HTS_TST_POS Service Delivery Point by Agg Age (Facility) TB: 15+, Male, Positive 2018 4
HTS_TST_POS Service Delivery Point by Agg Age (Facility) VCT: 15+, Female, Positive 2018 21
HTS_TST_POS Service Delivery Point by Agg Age (Facility) VCT: 15+, Male, Positive 2018 10
KP_PREV By key population type: Men who have sex with men who are NOT sex workers (Numerator: Number of key populations reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required) 2018 397
KP_PREV Number of key populations reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required 2018 397
PMTCT_ART Already on ART at beginning of current pregnancy 2018 48
PMTCT_ART New on ART 2018 37
PMTCT_ART Number of HIV-positive pregnant women who received ART to reduce risk of mother-to-child-transmission (MTCT) during pregnancy 2018 85
PMTCT_ART Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2018 4,985
PMTCT_EID Number of infants who had a virologic HIV test within 12 months of birth during the reporting period 2018 85
PMTCT_EID Number of infants with a negative virological test result within 2 months of birth 2018 83
PMTCT_EID Unknown, <= 2 months 2018 2
PMTCT_STAT By Age (Numerator): 15-19 2018 105
PMTCT_STAT By Age (Numerator): 20-24 2018 1,887
PMTCT_STAT By Age (Numerator): 25-49 2018 2,993
PMTCT_STAT By Number of known positives: 20-24 2018 18
PMTCT_STAT By Number of known positives: 25-49 2018 19
PMTCT_STAT By Number of new negative: 15-19 2018 105
PMTCT_STAT By Number of new negative: 20-24 2018 1,850
PMTCT_STAT By Number of new negative: 25-49 2018 2,945
PMTCT_STAT By Number of new positives: 20-24 2018 19
PMTCT_STAT By Number of new positives: 25-49 2018 29
PMTCT_STAT Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2018 4,985
PMTCT_STAT_den By Age (Denominator): <15-19 2018 108
PMTCT_STAT_den By Age (Denominator): 20-24 2018 1,945
PMTCT_STAT_den By Age (Denominator): 25-49 2018 3,086
TB_ART Aggregated Age/Sex: Female 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2018 4
TB_ART Aggregated Age/Sex: Male 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2018 12
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period 2018 16
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period 2018 16
TB_ART_den Aggregated Age/Sex: Female 15+ (Denominator: The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period) 2018 4
TB_ART_den Aggregated Age/Sex: Male 15+ (Denominator: The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period) 2018 12
TB_PREV By Age/Sex (Numerator): <15, Female 2018 8
TB_PREV By Age/Sex (Numerator): <15, Male 2018 2
TB_PREV By Age/Sex (Numerator): 15+, Female 2018 235
TB_PREV By Age/Sex (Numerator): 15+, Male 2018 202
TB_PREV By Therapy type (Numerator): 6-12 Month IPT 2018 447
TB_PREV The number of ART patients who completed a course of TB preventive therapy or at least 6 months of Isoniazid Preventive Therapy (IPT) during the reporting period 2018 447
TB_PREV The number of ART patients who were newly started on TB preventive therapy (including those who newly started on TB preventive therapy in this reporting period and those who started in the previous reporting period but had not been reported as they did not fulfill the minimum requirements for the previous reporting period) 2018 471
TB_PREV_den By Age/Sex (Denominator): <15, Female 2018 8
TB_PREV_den By Age/Sex (Denominator): <15, Male 2018 2
TB_PREV_den By Age/Sex (Denominator): 15+, Female 2018 248
TB_PREV_den By Age/Sex (Denominator): 15+, Male 2018 213
TB_PREV_den By Therapy type (Denominator): 6-12 Month IPT 2018 471
TB_STAT Aggregated Age/Sex: Female 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2018 15
TB_STAT Aggregated Age/Sex: Male 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2018 70
TB_STAT Number of registered new and relapsed TB cases with documented HIV status, during the reporting period 2018 85
TB_STAT Total number of registered new and relapsed TB cases, during the reporting period 2018 85
TB_STAT_den Aggregated Age/Sex: Female 15+ (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2018 15
TB_STAT_den Aggregated Age/Sex: Male 15+ (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2018 70
TX_CURR Aggregated Age/Sex: <15 Female 2018 5
TX_CURR Aggregated Age/Sex: <15 Male 2018 17
TX_CURR Aggregated Age/Sex: 15+ Female 2018 436
TX_CURR Aggregated Age/Sex: 15+ Male 2018 789
TX_CURR Number of adults and children receiving antiretroviral therapy (ART) 2018 1,247
TX_CURR Sum of Aggregated Age/Sex <15 2018 22
TX_CURR Sum of Aggregated Age/Sex 15+ 2018 1,225
TX_CURR Sum of Aggregated Age/Sex disaggregates 2018 1,247
TX_NEW Aggregated Grouping by Age/Sex: <15 Female 2018 3
TX_NEW Aggregated Grouping by Age/Sex: <15 Male 2018 13
TX_NEW Aggregated Grouping by Age/Sex: 15+ Female 2018 132
TX_NEW Aggregated Grouping by Age/Sex: 15+ Male 2018 215
TX_NEW Breastfeeding status 2018 34
TX_NEW Number of adults and children newly enrolled on antiretroviral therapy (ART) 2018 363
TX_NEW Pregnancy status 2018 51
TX_NEW Sum of Aggregated Age/Sex disaggregates 2018 363
TX_PVLS Number of adult and pediatric ART patients with a viral load result documented in the patient medical record and /or laboratory records in the past 12 months 2018 773
TX_PVLS Number of adults and pediatric patients on ART with suppressed viral load results (<1,000 copies/ml) documented in the medical records and /or supporting laboratory results within the past 12 months 2018 628
TX_PVLS Numerator: Aggregate Age/Sex by Indication: <15 Female Targeted 2018 2
TX_PVLS Numerator: Aggregate Age/Sex by Indication: <15 Male Targeted 2018 7
TX_PVLS Numerator: Aggregate Age/Sex by Indication: 15+ Female Targeted 2018 182
TX_PVLS Numerator: Aggregate Age/Sex by Indication: 15+ Male Targeted 2018 437
TX_PVLS Numerator: Indication: Targeted 2018 628
TX_PVLS Numerator: Preg/BF by Indication: Breastfeeding Targeted 2018 34
TX_PVLS Numerator: Preg/BF by Indication: Pregnant Targeted 2018 51
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: <15 Female Targeted 2018 4
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: <15 Male Targeted 2018 11
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: 15+ Female Targeted 2018 334
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: 15+ Male Targeted 2018 424
TX_PVLS_den Denominator: Indication: Targeted 2018 773
TX_PVLS_den Denominator: Preg/BF by Indication: Breastfeeding Targeted 2018 34
TX_PVLS_den Denominator: Preg/BF by Indication: Pregnant Targeted 2018 51
TX_RET Aggregated Age/Sex: <15 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2018 4
TX_RET Aggregated Age/Sex: <15 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2018 2
TX_RET Aggregated Age/Sex: 15+ Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2018 33
TX_RET Aggregated Age/Sex: 15+ Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2018 78
TX_RET Number of adults and children who are still alive and on treatment at 12 months after initiating ART 2018 117
TX_RET Numerator by Status: Breastfeeding 2018 12
TX_RET Numerator by Status: Pregnant 2018 17
TX_RET Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up 2018 129
TX_RET_den Aggregated Age/Sex: <15 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2018 5
TX_RET_den Aggregated Age/Sex: <15 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2018 2
TX_RET_den Aggregated Age/Sex: 15+ Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2018 35
TX_RET_den Aggregated Age/Sex: 15+ Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2018 87
TX_RET_den Denominator by Status: Breastfeeding 2018 13
TX_RET_den Denominator by Status: Pregnant 2018 19
TX_TB Number of ART patients who were screened for TB at least once during the reporting period 2018 873
TX_TB Number of ART patients who were started on TB treatment during the reporting period 2018 44
TX_TB Numerator: By Aggregated Age/Sex: 15+, Female 2018 11
TX_TB Numerator: By Aggregated Age/Sex: 15+, Male 2018 33
TX_TB_den Denominator: By Aggregated Age/Sex: 15+, Female 2018 218
TX_TB_den Denominator: By Aggregated Age/Sex: 15+, Male 2018 655
TX_TB_den Denominator: By Diagnostic Test [Subdisagg of Specimen Sent]: Smear Only 2018 873
TX_TB_den Denominator: By Screen Result: Negative 2018 829
TX_TB_den Denominator: By Screen Result: Positive 2018 44
TX_TB_den Denominator: By Specimen Sent: Number of ART patients who had a specimen sent for bacteriologic diagnosis of active TB disease 2018 873